Tom Cascino, MD (@tomcascinomd) 's Twitter Profile
Tom Cascino, MD

@tomcascinomd

HF/Tx @umichCVC & @UM_IHPI | #SSOM & @UCSF alum | Working to improve the lives of people with #HeartFailure & #PAH | Michigan Sports Fan

ID: 895270871643959296

calendar_today09-08-2017 13:09:43

215 Tweet

639 Followers

997 Following

Clyde Yancy, MD, MSc (@nmhheartdoc) 's Twitter Profile Photo

#AHA23 Pecha Kucha Heart Failure Session - best 7 min, 20 graphic presentation winner? Nosheen Reza, MD, MS #awesome ๐Ÿ‘๐Ÿฝ๐Ÿ‘๐Ÿฝ๐Ÿ‘๐Ÿฝ Stay tuned for encore presentation next year! #NewStandard

#AHA23 Pecha Kucha Heart Failure Session - best 7 min, 20 graphic presentation winner? <a href="/noshreza/">Nosheen Reza, MD, MS</a> #awesome ๐Ÿ‘๐Ÿฝ๐Ÿ‘๐Ÿฝ๐Ÿ‘๐Ÿฝ
Stay tuned for encore presentation next year! #NewStandard
PR Assembly (@pr_assembly) 's Twitter Profile Photo

Really thorough presentation from Prof Carly Rochester on the new American Thoracic Society (ATS) PR Assembly #CPG with consideration of the evidence-based recommendations, unmet research needs and strategies for implementation. With thanks to the panel Surya P Bhatt, MD, MSPH Tom Cascino, MD Linzy Houchen-Wolloff ๐Ÿ’ป

Really thorough presentation from Prof Carly Rochester on the new <a href="/atscommunity/">American Thoracic Society (ATS)</a> <a href="/PR_Assembly/">PR Assembly</a> #CPG with consideration of the evidence-based recommendations, unmet research needs and strategies for implementation. With thanks to the panel <a href="/suryapbhatt/">Surya P Bhatt, MD, MSPH</a> <a href="/TomCascinoMD/">Tom Cascino, MD</a> <a href="/LinzyWolloff/">Linzy Houchen-Wolloff</a> ๐Ÿ’ป
Jason Weatherald MD (@albertaphdoc) 's Twitter Profile Photo

Couldnโ€™t coordinate all of us, but here is most of our Task Force 11 getting ready for our session today. You will note that since we are a forward-looking group planning the next innovative clinical trials in PH, we are already in the future (2042) ๐Ÿ˜‰ #WSPH2024 WSPH Association

Couldnโ€™t coordinate all of us, but here is most of our Task Force 11 getting ready for our session today. You will note that since we are a forward-looking group planning the next innovative clinical trials in PH, we are already in the future (2042) ๐Ÿ˜‰ #WSPH2024 <a href="/AssociationWsph/">WSPH Association</a>
Jason Weatherald MD (@albertaphdoc) 's Twitter Profile Photo

๐Ÿšจ๐ŸšจHot of the press ๐Ÿ”ฅ๐Ÿ”ฅ Excited to share out Task Force 11 document from the WSPH Association on #ClinicalTrial design, endpoints, and emerging therapies in #PAH erj.ersjournals.com/content/early/โ€ฆ Dr Mardi Gomberg Tom Cascino, MD Mitchell Psotka Roham Zamanian ERS publications James D Chalmers Don Sin

Manreet Kanwar (@manreetkanwar) 's Twitter Profile Photo

LVADs should be considered as an option for net prolongation of life in young pts. Aditi Nayak Tom Cascino, MD Vanessa Blumer, MD, FACC Katherine Wood Stavros George Drakos Mark Belkin Ryan J Tedford MD STS Intermacs 2024 Annual Report: Focus on Outcomes in Younger Patients annalsthoracicsurgery.org/article/S0003-โ€ฆ

Aditi Nayak (@aditinayakmd) 's Twitter Profile Photo

1/ ๐Ÿ”ฅCheck out the latest #STS Intermacs annual report ๐Ÿ‘‡๐Ÿฝ We demonstrate ongoing excellent outcomes for #LVAD patients, AND much better outcomes for #BiVADs in the contemporary era, with a special ๐Ÿ”ฌon young patients (<50 years) annalsthoracicsurgery.org/article/S0003-โ€ฆ

JHLT (@thejhlt) 's Twitter Profile Photo

Despite evolving treatment options for #PAH, morbidity & mortality remain high. Sotatercept, a novel activin signaling inhibitor, shows promise. This review explores its mechanism, patient outcomes, and safety. Tom Cascino, MD ๐Ÿ”—: jhltonline.org/article/S1053-โ€ฆ

Journal of Cardiac Failure (@jcardfail) 's Twitter Profile Photo

Check out these highlights from the World Symposium on PH, curated specifically for the HF cardiologist ๐ŸŒŽ๐Ÿซ€ From phenotyping PH-Left Heart Disease to considering how to incorporate sotatercept, this #JCF piece has you covered with the latest. ๐Ÿ”— bit.ly/3BZDhjP

Check out these highlights from the World Symposium on PH, curated specifically for the HF cardiologist ๐ŸŒŽ๐Ÿซ€  

From phenotyping PH-Left Heart Disease to considering how to incorporate sotatercept, this #JCF piece has you covered with the latest.

๐Ÿ”— bit.ly/3BZDhjP
Kay Everett, MD, PhD (@kayeverettmdphd) 's Twitter Profile Photo

The GRS on Assisted Circulation is coming up soon! Check out the program ๐Ÿ‘‰ grc.org/assisted-circuโ€ฆ ๐Ÿ’กIf you havenโ€™t applied yet, thereโ€™s still time โ€” the deadline is May 10. ๐Ÿ™Reposts appreciated!

The GRS on Assisted Circulation is coming up soon! Check out the program ๐Ÿ‘‰ grc.org/assisted-circuโ€ฆ
๐Ÿ’กIf you havenโ€™t applied yet, thereโ€™s still time โ€” the deadline is May 10. 
๐Ÿ™Reposts appreciated!
The ISHLT (@ishlt) 's Twitter Profile Photo

#ISHLT appoints the first non-physician Scientific Program Chair for #ISHLT2027, Melissa Cousino, PhD.ย ๐ŸŽ‰๐Ÿซ€๐Ÿซ "As the first transplant psychologist and allied health professional in this role, this highlights the ISHLTโ€™s tremendous commitment to uplifting the multidisciplinary

#ISHLT appoints the first non-physician Scientific Program Chair for #ISHLT2027, Melissa Cousino, PhD.ย ๐ŸŽ‰๐Ÿซ€๐Ÿซ

"As the first transplant psychologist and allied health professional in this role, this highlights the ISHLTโ€™s tremendous commitment to uplifting the multidisciplinary
PR Assembly (@pr_assembly) 's Twitter Profile Photo

With huge thanks to our expert panel of speakers PR Assembly for the symposium session A87:ย  Virtual Pulmonary Rehabilitation: A Pro/con debate. Key message: Virtual PR is an option for selected patients but it needs to be adequately prescribed and supervised. ๐Ÿ’ป ๐Ÿ’ช

With huge thanks to our expert panel of speakers <a href="/PR_Assembly/">PR Assembly</a> for the symposium session A87:ย  Virtual Pulmonary Rehabilitation: A Pro/con debate. 
Key message: Virtual PR is an option for selected patients but it needs to be adequately prescribed and supervised. ๐Ÿ’ป ๐Ÿ’ช